why choose us

Clinical Trials Search

Showing 13,200 of 132,366 result(s)
HFIT Versus TENS Study for Chronic Low Back and Knee Pain

Status: ACTIVE_NOT_RECRUITING

Condition: Chronic Pain

Interventions: At least 1 hour daily for 4 weeks

Date: 2023-04-06

Pounce™ Thrombectomy System Retrospective Registry

Status: Completed

Condition: Peripheral Arterial Disease

Interventions: Non-surgical removal of thrombi and emboli from the peripheral arterial vasculature with the Pounce Thrombectomy System.

Date: 2023-04-06

Role of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary Syndrome

Status: Completed

Condition: PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries

Interventions: 10 months of semaglutide, with dose escalation as recommended by manufacturer.
Maximum dose used will be 1.7mg

Date: 2023-04-06

Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Change in Cardiovascular Health

Status: Completed

Condition: Coronary Artery Disease

Interventions: The disclosure of a high polygenic risk result for coronary artery disease involves a clinical report coupled with a virtual meeting with a genetic co

Date: 2023-04-06

A Study to Explore if Long-term Use of Mucinex Can Help With Symptoms in Patients With Stable Chronic Bronchitis.

Status: Completed

Condition: Chronic Bronchitis

Interventions: During the 12-week period of receiving treatment, patient participants will take Mucinex® 12h, 2 x 600 mg (1200 mg total) twice daily.

Date: 2023-04-06

The Cohort Study of the Correlation Between Serum 25(OH)D Level and Pregnancy Outcome

Status: Completed

Condition: Vitamin D Deficiency

Interventions: Subjects in this study are grouped according to baseline serum levels of 25(OH)D.
The serum level of total 25(OH)D ?30ng;ml (75nM) is suffic

Date: 2023-04-06

Bupivacaine Versus Bupivacaine Plus Lidocaine in Infraclavicular Block

Status: COMPLETED

Condition: Pain, Acute

Interventions: Infraclavicular block with 35 ml of the following anesthetic solution: Bupivacaine 0.25% + Lidocaine 1% + dexamethasone 4 mg + epinephrine 5 mcg;

Date: 2023-04-06

Y-3 Injection Through Skull Bone Marrow in the Treatment of Acute Malignant Middle Cerebral Artery Infarction (SOLUTION)

Status: Completed

Condition: Stroke, Acute Ischemic

Interventions: Intracalvaria bone marrow injection Y-3 (dose was given at 32 ug;kg), continuous medication for 3 days

Date: 2023-04-06